Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, autosomal recessive inherited disorder usually caused by mutations in the THRB gene. It is characterized by a defective physiological resistance to thyroid hormones, resulting in the elevation of thyroxin and triiodothyronine in the serum.
Features include always present findings: Increased body weight, Increased circulating T4 concentration, Anti-thyroid peroxidase antibody positivity, and Fatigue and others; and common findings: Anti-thyroglobulin antibody positivity, Anti-thyroid-stimulating hormone receptor antibody positivity, and Elevated circulating thyroid-stimulating hormone concentration. 18 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 7 |
THRB function has not been fully characterized.
Thyroid hormone resistance, generalized, autosomal recessive is associated with mutations in the THRB gene on chromosome 3.
Genetic testing for THRB is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for thyroid hormone resistance, generalized, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 10 always present features, 3 common features.
No clinical trials have been registered for thyroid hormone resistance, generalized, autosomal recessive.
72 publications have been identified in PubMed for thyroid hormone resistance, generalized, autosomal recessive. Research spans Case Report / Case Series (42%), Epidemiology / Natural History (24%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 | 42% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:03 PM UTC
Online Mendelian Inheritance in Man
Lab test results | 6 | Increased circulating T4 concentration, Anti-thyroid peroxidase antibody positivity, Anti-thyroglobulin antibody positivity |
Ears | 1 | Hearing loss (hearing impairment) |
Brain and nerves | 1 | Fatigue |
Disease patterns and progression |
17 |
24% |
Laboratory research | 13 | 18% |
Research summaries | 5 | 7% |
New treatment approaches | 4 | 6% |
Testing and diagnosis research | 2 | 3% |
Other research | 1 | 1% |
Shelly M (2026). [PMID: 41837232](https://pubmed.ncbi.nlm.nih.gov/41837232/). *JCEM case reports*. [Case Report / Case Series]
Wang Y (2026). [PMID: 41888467](https://pubmed.ncbi.nlm.nih.gov/41888467/). *Hormones (Athens)*. [Epidemiology / Natural History]
Liao LY (2026). [PMID: 41582758](https://pubmed.ncbi.nlm.nih.gov/41582758/). *Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics*. [Basic Science / Preclinical]
Li C (2026). [PMID: 41739686](https://pubmed.ncbi.nlm.nih.gov/41739686/). *The oncologist*. [Epidemiology / Natural History]
Wu X (2026). [PMID: 42237874](https://pubmed.ncbi.nlm.nih.gov/42237874/). *Biol Open*. [Basic Science / Preclinical]
Awad MH (2026). [PMID: 42228305](https://pubmed.ncbi.nlm.nih.gov/42228305/). *Endocrine*. [Case Report / Case Series]
Yang Z (2026). [PMID: 42065173](https://pubmed.ncbi.nlm.nih.gov/42065173/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Yang J (2026). [PMID: 41649337](https://pubmed.ncbi.nlm.nih.gov/41649337/). *Archives of endocrinology and metabolism*. [Epidemiology / Natural History]
Agrawal R (2026). [PMID: 41818104](https://pubmed.ncbi.nlm.nih.gov/41818104/). *The Journal of the Association of Physicians of India*. [Case Report / Case Series]
Pan YA (2026). [PMID: 41971634](https://pubmed.ncbi.nlm.nih.gov/41971634/). *JCEM Case Rep*. [Case Report / Case Series]